The fibroblast growth factor-4 (HST-1/FGF-4) is a heparin-binding growth factor that influences on epithelial and many other cells through interaction with FGF receptors. It has been demonstrated that the HST-1/ FGF-4 gene protects mice from lethal irradiation by preventing bone marrow damage and intestinal tract damage. However, the radioprotective mechanism is unknown. In this study, we have investigated the expression of Hst-1/Fgf-4 in mouse small intestine after irradiation, and determined the role of HST-1/FGF-4 in mouse intestinal crypt cell survival and epithelial cell proliferation and restitution. We found the induction of endogenous Hst-1/Fgf-4 expression in intestine when mice are exposed to 9.0 Gy irradiation. Laser-captured microdissection (LCM) coupled with RT-PCR analysis revealed that expression of Hst-1/Fgf-4 was found in epithelial cell of the villi and crypt cells. Pretreatment of HST-1/FGF-4 caused an increase in the number of surviving crypt cells, and clearly suppresses the radiation-induced apoptosis of the crypt cells. Moreover, exogenous HST-1/FGF-4 enhances epithelial cell restitution and proliferation in an in vitro model. These data suggest that HST-1/FGF-4 is induced by irradiation injury, and that HST-1/FGF-4 will find a therapeutic role in the prevention of intestinal cell toxicity following intensive chemotherapy and radiation therapy protocols, and in allogenic cell transplantation.
Introduction
The integrity of the mucosal epithelium of the intestine is maintained by an intricate cell replacement process. The epithelium of intestinal mucosa is composed of a dynamic continuum ranging from actively proliferating cells to terminally differentiated enterocytes lacking mitotic activity. Under normal conditions, intestinal epithelial cells develop from a single stem cell (Winton and Ponder, 1990; Cohn et al., 1992; Bach et al., 2000) .
Crypt stem cell dysfunction (mitotic arrest) with continued trafficking of crypt cells into the villus and loss of cells from the villus tip, resulting in shrinkage of the villus and loss of the protective barrier function, is the cause of the GI syndrome after irradiation. Radiation-induced gastrointestinal damage can result in a variety of symptoms ranging from mild diarrhea to electrolyte imbalance, and, in severe cases, septic shock and death (Potten, 1990) . Radiation kills rapidly dividing cancer cells, but the killing of rapidly proliferating tissues such as bone marrow and small intestinal crypts limits the dose that can be used in abdominal and pelvic radiation therapy.
The gastrointestinal mucosa has the ability to repair itself very rapidly. This rapid protective mechanism, called restitution, is a process that does not require proliferation. In vivo restitution has been observed to occur within minutes to hours after a low-dose exposure, and involves the sloughing of damaged epithelial cells and the migration of the remaining viable cells to re-establish epithelial continuity. Crypt stem cells also play a central role in mucosal regeneration following injury (Potten and Loeffler, 1990) . After injury, stem cells proliferate and give rise to a more rapidly proliferating transit cell population. The transit cell population expands rapidly to form a regenerative crypt, and normal patterns of epithelial differentiation are established by migration and differentiation of cells produced in these regenerative crypts. One surviving stem cell can repopulate a crypt after injury; moreover, if the injury has completely destroyed some crypts, the surviving crypt stem cells can divide to replete the number of viable crypts (Potten, 1990) . Regeneration through epithelial cell proliferation and differentiation requires at least 1-2 days (Feil et al., 1987; Lacy, 1988; Nusrat et al., 1992) .
In recent years, several cytokines and growth factors that protect radiation-induced intestinal damage have been identified (Okunieff et al., 1988; Roberts et al., 1993; Leigh et al., 1995; Khan et al., 1997; Potten et al., 1997; Farrell et al., 1998; Cutler et al., 2003) . Among them, we reported that fibroblast growth factor-4 (HST-1/FGF-4) protects mice from lethal irradiation by preventing bone marrow damage and intestinal tract damage (Takahama et al., 1999) . However, little is known about the roles of HST-1/FGF-4 in crypt cell survival and reconstitution of intestinal epithelial cells. In this study, we have investigated the expression of Hst-1/Fgf-4 in mouse small intestine after irradiation and determined the role of HST-1/FGF-4 in mouse intestinal crypt cell survival and epithelial cell proliferation and restitution. We report that: (1) the endogenous Hst-1/ Fgf-4 protein level is upregulated in the small intestine after irradiation, (2) expression of Hst-1/Fgf-4 is found in epithelial cell of the villi and crypt cells, (3) HST-1/ FGF-4 clearly suppresses the radiation-induced apoptosis of the crypt cells, and (4) HST-1/FGF-4 enhances epithelial cell restitution and proliferation in a nontransformed rat intestinal epithelial cell line (IEC-6). These results suggest that HST-1/FGF-4 may be useful for preventing intestinal cell toxicity following intensive chemotherapy and radiation therapy protocols.
Results

Induced expression of endogenous Hst-1/Fgf-4 by irradiation in vivo
It is reported that growth factors such as FGF-2, which are considered to play a protective role in tissue repair, were often induced by irradiation (Houchen et al., 1999) . To investigate whether endogenous Hst-1/Fgf-4 expression in the small intestine could be stimulated by irradiation, normal mice were exposed to 9.0 Gy irradiation and the intestinal protein level was monitored kinetically. As shown in Figure 1 , levels of endogenous Hst-1/Fgf-4 began to increase at 72 h after irradiation, reaching peak levels at 96 h postirradiation. Hst-1/Fgf-4 levels subsequently fell from 120 to 144 h after irradiation to the low levels that were present in unirradiated control mouse small intestine. These data show that irradiation induces expression of endogenous Hst-1/Fgf-4 in the small intestine in vivo, and suggest that Hst-1/Fgf-4 may possibly play physiological roles in the radiation-induced injury.
Hst-1/Fgf-4 is expressed in epithelial cells of the villi and crypt cells
To identify the expression of the genes in adult mouse intestine, LCM were used (Figure 2a ). After RNA extraction from these captured samples, RT-PCR amplification was performed. To ascertain our LCM Following RT-PCR amplification, the PCR products were separated by agarose gel electrophoresis, transferred onto a nylon membrane, and hybridized under high stringency conditions with a32P-labeled mouse Hst-1/Fgf-4 cDNA fragment as a probe (c, middle). The RNA samples were subjected to RT-PCR analysis of b-actin transcripts to verify the integrity (b, c, bottom). Whole proximal intestine was used as a positive control (PC) and no RNA sample was used as a negative control (NC) in (b), kidney was used as a negative control (NC) in (c) Figure 1 Induced expression of Hst-1/Fgf-4 by radiation. Mice received 9.0 Gy irradiation in a Gamma-cell 40 chamber. Protein was prepared from the proximal jejunum of mice killed at the indicated time point after irradiation, and subjected to Western blot analysis HST-1/FGF-4 plays a critical role in crypt survival H Sasaki et al procedure, RT-PCR amplification of Cytokeratin 18 was performed, since expression of Cytokeratin 18 is restricted to crypt cells (Figure 2b ). Expression of Cytokeratin 18 is restricted to samples from crypt cells. Using this method, we firstly investigated the expression of fgfr-1 and fgfr-2 in the mouse intestine. As shown in Figure 2b , fgfr-2 is expressed in epithelial cell of the villi and crypt cells, but fgfr-1 is not expressed in either samples. Next, we investigated the expression of the Hst-1/Fgf-4 in the small intestine, using the same method. As shown in Figure 2c , Hst-1/Fgf-4 gene is expressed in both samples. These results revealed that Hst-1/Fgf-4 is expressed in the epithelial cells of the villi and crypt cells.
HST-1/FGF-4 protects against radiation-induced intestinal damage
Administration of the adenovirus-carrying human HST-1/FGF-4 gene (AxHST-1) resulted in successful expression of the HST-1/FGF-4 gene, leading to increased serum HST-1/FGF-4 protein (16676 pg/ml at 4 days after the AxHST-1 administration), which was not disturbed by the irradiation regimens. In an attempt to assess the protective effect of AxHST-1, histological examinations were performed. At 14 days after irradiation, damage to the intestine was clearly observed in the histological section from mice administered a recombinant adenovirus vector that lacks reporter sequence (AxWt), but intestines from mice administered AxHST-1 were significantly different from the AxWt-treated group. As shown in Figure 3a , the villus length from AxHST-1-treated mice appeared significantly longer than the AxWt-treated control (Figure 3b ). Although data are not shown, AdexHST-1 rescued the intestinal injury of 3-12 Gy irradiation in mice. These results indicate that administration of AxHST-1 protects against radiation-induced intestinal damage.
HST-1/FGF-4 prevents radiation-induced apoptosis of the crypt cells Radiation-induced intestinal damage is due in part to the killing of the crypt stem cells. Thus, we assessed the effect of HST-1/FGF-4 on crypt cell survival after whole body irradiation, by the microcolony assay technique, for assaying the survival of small proportions of the crypt cells of the small intestine 3.5 days after irradiation. As shown in Figures 4a and b, treatment with AxHST-1 significantly increased the survival of irradiated crypts (Po0.003).
Previous studies show that FGF-1, FGF-2, and VEGF protect radiation-induced apoptosis of the crypt cells (Okunieff et al., 1988) . Next, we compared the level of radiation-induced apoptosis in vivo in the crypts of the small bowel at 4 h after the mice were given 9.0 Gy of whole-body irradiation (Figures 5a and 5b ). Normal small bowel had a minimally detectable frequency of spontaneous apoptosis in the control nonirradiated animals. In the irradiated animals, a high level of apoptosis was present in the small intestine, but apoptotic events were clearly suppressed in the AxHST-1-treated group. These results suggest that HST-1/FGF-4 enhances intestinal crypt cell survival by preventing radiation-induced apoptosis of the crypt cells. HST-1/FGF-4 plays a critical role in crypt survival H Sasaki et al
HST-1/FGF-4 enhances epithelial cell restitution and proliferation
After various forms of injury, mucosal integrity is reestablished by rapid migration of epithelial cells in a process termed restitution (Feil et al., 1987; Lacy, 1988; Nusrat et al., 1992) . To investigate this issue, we performed a cell-migration assay using IEC-6 cells, a nontransformed putative crypt cell line derived from rat small intestine and established as an in vitro model for gastrointestinal cell migration (McCormack et al., 1992) . As shown in Figure 6 , additional exogenous HST-1/FGF-4 can enhance epithelial cell migration in a dose-dependent manner. A dose of 2 mg/ml mitomycin C inhibited proliferation entirely, without affecting the viability of IEC-6 cells, as previously described (Dignass and Podolsky, 1993) . This mitomycin pretreatment was used to exclude the influence of cell proliferation. Migration was also observed after mitomycin C pretreatment (data not shown). These results demonstrate that HST-1/FGF-4 acts as a potent factor for epithelial cell restitution.
In the repair process of intestinal damage, regeneration occurs following restitution after various forms of injury. This regeneration occurs through epithelial cell proliferation. As shown in Figure 7 , cell proliferation in intestinal epithelial cell line IEC-6 can be stimulated in a dose-dependent manner. Thus, HST-1/FGF-4 enhances epithelial cell regeneration through epithelial cell proliferation. Therefore, the in vitro model of intestinal tissue repair revealed that additional recombinant HST-1/FGF-4 enhances epithelial cell restitution and proliferation in a dose-dependent manner.
Discussion
The early lethality associated with radiation is attributed to the killing of rapidly dividing cells in the bone marrow and the intestine. The tolerance of normal tissue to irradiation limits the dose that can be used in radiation therapy. An agent that could increase the therapeutic index of irradiation by decreasing toxicity to normal tissues without protecting tumor cells would be HST-1/FGF-4 plays a critical role in crypt survival H Sasaki et al of great clinical utility. In this report, we showed that overexpression of HST-1/FGF-4 enhances the survival of intestinal crypt cells by preventing radiation-induced apoptosis of the crypt cells in vivo, and activates the repair process of the intestine through epithelial cell restitution and proliferation in vitro.
We reported that HST-1/FGF-4 protects mice from lethal irradiation by preventing bone marrow injury and intestinal tract damage (Takahama et al., 1999) . This whole-body irradiation regimen induces lethality in mice, most likely as a result of lethal marrow and intestinal injuries (Wambersie et al., 1996) . Due to the fact that HST-1/FGF-4 targets both bone marrow and intestinal injuries, HST-1/FGF-4 gene-based therapy for systemic injury from whole-body irradiation is superior to any other radioprotective agents such as FGF-2 and KGF.
Previous studies have shown that IL-1, SCF, KGF, FGF-1, FGF-2, and VEGF enhance the survival of irradiated murine intestinal crypt cells (Okunieff et al., 1988; Roberts et al., 1993; Leigh et al., 1995; Khan et al., 1997) . Among them, FGF-1, FGF-2, and VEGF were reported to protect radiation-induced apoptosis of the crypt cells (Okunieff et al., 1988) , and it was reported that the apoptosis of the crypt cells reached a sustained peak 4 h after irradiation and then declined back to baseline level within 24 h. In our whole-body irradiation regimen, HST-1/FGF-4 clearly suppressed the apoptotic event in crypt cells 4 h after irradiation, and also increased the survival of the crypt cells 3.5 days after irradiation. From a clinical point of view, increasing crypt survival after radiation therapy could decrease radiation-induced damage in the intestine and thereby minimize some of the early and late side effects of gastrointestinal irradiation (Potten, 1990) . Thus, HST-1/FGF-4 might be clinically useful in decreasing radiation-induced damage to the intestine.
After superficial injury, restitution has been observed to occur within minutes to hours, and it has been reported that FGF-1, FGF-2, and TGF-b enhance epithelial cell restitution (Ciacci et al., 1993; Dignass and Podolsky, 1993; Dignass et al., 1994) . Studies of epithelial restitution in vivo are limited by the difficulty of distinguishing the effects of cell migration from the delayed phase of mucosal healing. To overcome the difficulties inherent in in vivo studies, we used an in vitro model of epithelial cell injury (Dignass and Podolsky, 1993; Wambersie et al., 1996) . In this in vitro model of epithelial restitution, HST-1/FGF-4 clearly enhances epithelial cell restitution in a dose-dependent manner. Santos et al. (1997) have investigated the role of the Rho subfamily GTPases in IEC-6 cells, and found that Rho proteins play an essential role in the early phase of mucosal wound healing through the regulation of growth factor-induced cell migration. Whether HST-1/ FGF-4 promotes actin remodeling through a downstream Rho-dependent pathway and promotes epithelial restitution awaits further analysis. Although restitution plays only a little role in repair mechanisms in vivo after a high dose of radiation, HST-1/FGF-4 enhances epithelial restitution in the in vitro model of the epithelial cell injury. These results suggest that HST-1/ FGF-4 may possibly play a role in epithelial cell restitution in vivo.
It is clear that crypt stem cell proliferation is an important step in epithelial regeneration. In the repair process of intestinal damage, regeneration occurs following restitution. Previous study shows that FGF-1, FGF-2, and KGF enhance epithelial cell proliferation in an in vitro model (Dignass et al., 1994) . In this model of epithelial cell proliferation, exogenous HST-1/FGF-4 protein also enhances epithelial cell proliferation in a dose-dependent manner.
HST-1/FGF-4 is a family of heparin-binding proteins, and has been identified as the ligand for a cell-surface tyrosine kinase receptor (FGFRs). Although it has been shown both in cells and in soluble receptor assay that HST-1/FGF-4 binds to FGFR-1 and FGFR-2 with similar affinity, previous study shows that HST-1/FGF-4 binds only to FGFR-2 at low concentrations of heparin, while much higher heparin levels are required for binding to FGFR-1 (Aviezer et al., 1999) . The target disruption of the FGFR-2 gene is embryonic lethal (Arman et al., 1998) . This early lethal phenotype is remarkably similar to that of HST-1/FGF-4 (Feldman et al., 1995; Ochiya, 1997) . From these observations, HST-1/FGF-4 and FGFR-2 may share a functional physiological role (Aviezer et al., 1999) . In fact, immunohistochemical staining revealed that the expression of FGFR-1 is confined to the microvasculature (Hughes and Hall 1993) . We revealed that both mouse Hst-1/Fgf-4 and Fgfr-2 are expressed in the epithelial cells of the villi and crypt cells, and Fgfr-1 is not expressed in either lesion. These observations strongly suggest that HST-1/FGF-4 may act through FGFR-2 in intestine.
HST-1/FGF-4 has a number of biological activities: it has potent transforming potential, apparently through an autocrine mechanism of action (Wright and Huang 1996) , and it acts as a potent angiogenic factor (Yoshida et al., 1994; Deroanne et al., 1997) . Therefore, there is potential for HST-1/FGF-4 to stimulate tumor growth in vivo when AxHST-1 is used in a clinical setting for anticancer therapy. The amount of AxHST-1 used in this experiment did not alter the growth rate or neovascularization of tumors implanted with ras-transformed NIH3T3 cells in nude mice (unpublished observations). Moreover, AxHST-1-treated mice produced no tumor growth in more 1 year and 6 months in our experiment (unpublished observations). Although further careful analyses are required, these observations suggest that a therapeutically effective dose of AxHST-1 may not cause tumor progression in patients undergoing radiation therapy.
In recent years, it is reported that gastrointestinal syndrome is primarily due to microvessel endothelial cell apoptosis, which initiates epithelial damage (Paris et al., 2001) . In fact, angiogenic growth factors such as aFGF, bFGF, and VEGF were radioprotective in a small bowel, whether given 24 h before or 1 h after irradiation (Okunieff et al., 1988) . This protective effect of bFGF may act through FGFR-1 and -2 in the intestine, which are expressed in microvasculature and are not expressed in crypt epithelial cells (Paris et al., 2001 ). Since our HST-1/FGF-4 showed angiogenic activity in vitro and in vivo, it is interesting to evaluate the antiapoptotic ability of HST-1/FGF-4 on endothelial cells. However, significant endothelial apoptosis was not observed when we evaluated under a total body irradiation of 9 Gy. Furthermore, LCM coupled with RT-PCR analysis revealed that expression of Fgfr-2 was found in epithelial cell of the villi, crypt cells. Therefore, whether primary lesion of the radiation-induced gastrointestinal damage is endothelial apoptosis awaits further precise analysis.
In summary, overexpression of HST-1/FGF-4 prevents radiation-induced apoptosis of the crypt cells and activates the repair process of the intestine through epithelial cell migration and proliferation. Further analysis is required to know whether HST-1/FGF-4 would be of clinical value in preventing radiationinduced gastrointestinal toxicity
Materials and methods
Adenovirus
To overexpress HST-1/FGF-4 protein in mice, we used the recombinant adenovirus carrying human HST-1/FGF-4 gene (AxHST-1), which contains the SRa promoter, human HST-1/ FGF-4 cDNA, and the simian virus 40 poly (A) signal sequence inserted into the E1-deleted region of a cosmid vector obtained by in vivo recombination, as described . As a control, a recombinant adenovirus vector that lacks reporter sequence (AxWt) was used.
Experimental protocol on animals
Pubertal (7-week-old) male ICR mice (purchased from CLEAJapan, Inc., Shizuoka, Japan) were housed in a standard animal facility with a controlled temperature (221C) and photoperiod (12 h light : 12 h dark). In an attempt to assess the radioprotective effectiveness of HST-1/FGF-4, we used a murine whole-body irradiation model. We injected 1 Â 10 9 p.f.u. of AxHST-1 (purified through CsCl step-gradient centrifugation as described and adjusted to 1 Â 10 9 p.f.u./ml, i.p.) into mice 4 days prior to the 9.0 Gy irradiation. Irradiation was carried out in a Gamma-cell 40 chamber containing the source of 60 Co at a dose rate of 0.3 Gy/s.
Western blot analysis
Proteins were extracted from the intestine. Tissues were weighted and ground into powder while in liquid nitrogen, and were then lysed in ice-cold RIPA buffer (50 mM Tris, 1.0% NP40, 150 mM NaCl, 0.1% SDS, 5 mM EDTA, 0.1 mM sodium orthovanadate, 0.1 mM NaF) containing protease inhibitor cocktail (Sigma-Aldrich). Lysates were subsequently clarified by centrifugation. The protein concentration was determined by a Bradford protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Approximately 100 mg of protein was subjected to SDS-PAGE in 15% gels, after which the protein was electroblotted to polyvinylidene difluoride membranes. The blot was blocked with 5% skim milk in Tris-buffered saline (10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.05% Tween 20). The antibody used for Western blot analysis was goat polyclonal anti mouse Fgf-4 (Santa-Cruz Biotechnology, Inc., Santa Cruz, CA, USA). After the blots were incubated for another 1 h at room temperature with horseradish peroxidase rabbit anti-goat antibody, the signal was detected using Enhanced Chemiluminance assay (Amersham Pharmacia Biotech, Inc, Piscataway, NJ, USA).
ELISA
The serum concentrations of HST-1/FGF-4 protein were measured by ELISA. Total blood was drawn from the heart of the anesthetized mice. The amount of serum HST-1/FGF-4 protein was detected by indirect ELISA using mouse antihuman FGF-4 monoclonal IgG (R&D Sytems, Inc., USA), as described .
Crypt survival
We injected 1 Â 10 9 p.f.u. of AxHST-1 or AxWt 4 days prior to irradiation. Crypt survival was measured in mice killed 3.5 days after irradiation, using a modification of the microcolony assay (Withers and Elkind, 1970; Cohn et al., 1997) . The mice received an intraperitoneal injection of 5-BrdU (100 mg/kg body weight, Sigma-Aldrich, Japan) 2 h before being killed. The intestine of each animal was fixed with 4% formaldehyde and embedded in paraffin. Sections were made and processed immunohistochemically using a BrdU staining kit (Roche Diagnostics, GmbH, Germany), according to the manufacturer's protocol. Briefly, 5 mm paraffin sections were prepared from the proximal jejunum oriented, so that the sections were cut perpendicular to the long axis of the small intestine. For the microcolony assay, a regenerative crypt was confirmed by immunohistochemical detection of BrdU incorporation into five or more epithelial cells within each regenerative crypt. A minimum of eight complete cross sections were scored for each mouse. Representative kinetic data were obtained from three mice in the AxWt-treated group and from four mice in the AxHST-1-treated group. Since the size of the regenerating crypt may not be the same for each treatment group, the number of surviving crypt per cross section was corrected for crypt size to control for the effect of treatment on the probability of observing a regenerative crypt within a section. The width of 15 representative crypts for each animal was measured in longitudinal sections on the proximal jejunum at the widest point in each crypt, and the mean surviving crypts per circumference was corrected for the variation in crypt size, as previously described (Potten et al., 1981) .
Tunel technique
To assess the number and localization of apoptotic cells, in situ detection of cells with DNA strand breaks was performed in 4%-formalin-fixed, paraffin-embedded intestinal section by the TUNEL technique using an In Situ Cell Death Detection Kit, Fluorescein (Roche Diagnostics GmbH, Mannheim, Germany), according to the manufacturer's protocol. In brief, the deparaffinized tissue sections were rehydrated and then treated with proteinase K (20 mg/ml, Roche Diagnostics, Inc.) in a 10 mM Tris-HCl (pH7.4) at 371C for 15 min. An aliquot of a 3 0 -end-labeling reaction mixture containing TdT and FITCconjugated nucleotides was applied and incubated in a humidified chamber at 371C for 1 h. Finally, the number of FITC-positive cells was determined by fluorescence microscopy.
Scoring was restricted to good longitudinal sections of the crypt in which the base of the crypt was aligned with all the other crypt bases, and evidence showed the crypt lumen to be present. At least 100 good longitudinal sections were selected per animal and apoptotic cells at cell positions 1-7 were scored as previously described Potten et al., 1992) .
Wounding assay
Wounding assay was essentially performed as previously described (Ciacci et al.,. 1993; Dignass and Podolsky, 1993; Dignass et al., 1994) . IEC-6 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Confluent monolayers of IEC-6 cells in 60-mm plastic dishes were wounded with a cell scraper. Cells were washed with a fresh serum-deprived medium, and the wounded monolayers were further cultured for 24 h in a fresh serum-deprived medium in various concentrations of Recombinant Human FGF-4 (R&D Sytems, Inc., USA) in the presence of heparin (1 mg/ml). Migration of IEC-6 cells was assessed in a blinded fashion to avoid observer bias, by determination of the number of IEC-6 cells observed across the wound border expressed as the mean number of cells found across the wound border in a standardized wound area. Wound areas were standardized by taking photomicrographs using an inverted microscope. Experiments were performed in triplicates, and several wound areas per plate were used to quantitate migration. Data presented under results are expressed as the mean value7s.d. of at least three independent experiments.
Cell proliferation assay
Cells (IEC-6) were seeded into 24-well plates (1 Â 10 4 cells/well) in the presence of Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS). After 24 h, cells were washed three times with PBS (-) and then cultured for an additional 24 h in DMEM containing 0.1% FBS (Dignass et al., 1994) . Cultures were then supplemented with recombinant human HST-1/FGF-4 (R&D Sytems, Inc., USA) in concentrations ranging from 1 to 10 ng/ml in the presence of heparin (1 mg/ml). After 22 h, TetraColor ONE (Seikagaku Co., Tokyo, Japan) was added to the culture medium; after 2 h, cell proliferation assay was performed according to the manufacturer's protocol.
RT-PCR analysis
Total RNAs were prepared using ISOGEN solution (NipponGene) according to the manufacturer's protocol. Briefly, aliquots of the total RNA isolated from the intestine were treated with DNase (DNase I, amplification grade; Life Technologies, Inc., Gaithersburg, MD, USA). First-strand cDNA synthesis was performed with First-strand cDNA Synthesis Kit (Amersham Pharmacia Biotech). PCR amplification was performed with the TaKaRa Ex TaqTM (TA-KARA SHUZO CO., Ltd), using the following primers: 5 0 -CCGTGAAGATGTTGAAGTCCGA-3 0 and 5 0 -CAAAA GACCACACATCGCTCTG-3 0 for FGFR-1, 5 0 -CAGCTTA CGATTCTTCAGCACC-3 0 and 5 0 -TAGGCCAGTCTTTT GTGAGGTG-3 0 for FGFR-2, according to the manufacturer's instructions, with each cycle in a TAKARA Thermal Cycler using the appropriate cycle profile.
For amplification of the Hst-1/Fgf-4 gene, RT-PCR reaction was performed with the SuperScriptTM One-Step RT-PCR with Platinum Taq (Invitrogen Life Technologies), with the primers 5 0 -GGGTGTGGTGAGCATCTTCGGA-3 0 and 5 0 -GGTATGCGTAGGACTCGTAGGGC-3 0 for Hst-1/ Fgf-4 gene. After PCR amplification, aliquots were electrophoresed on 3.0% agarose gels, stained with ethidium bromide, and then photographed under UV illumination. DNAs were denatured with 0.5 N NaOH-1.5 M NaCl, and then transferred onto a nylon membrane (Hybond N plus, Amersham), and hybridized with a probe; a a32P-labeled mouse Hst-1/Fgf-4 cDNA fragment in 5 Â Denhardt's solution (1 Â Denhardt's ¼ 0.02% Ficoll, 0.02% bovine serum albumin, 0.02% polyvinylpyrrolidone), 0.5% sodium dodecyl sulfate (SDS), 5 Â sodium saline phosphate EDTA (1 Â sodium saline phosphate EDTA ¼ 150 mM NaCl, 10 mM sodium phosphate, 1.3 mM EDTA), and 200 mg/ml of salmon sperm DNA at 651C. The images were incorporated into a Macintosh computer through a STORM image scanner (Molecular Dynamics). The intensity of each band on the image was measured and the data were processed by an imageprocessing software ImageQuaNT. b-actin cDNA was amplified as an internal control, using primers 5 0 -GACATCAAA GAGAAGCTGTGC-3 0 and 5 0 -TAGGAGCCAGAGCAGT AATC-3 0 .
Statistical analysis
The results are represented as means7s.d. A Student's t-test was performed for statistical evaluation, with Po0.05 considered as significant.
